Das Beste für das Individuum – das Wesentliche für alle
-
Erwin-Schrödinger-Saal
Plenary
/
German and English languageDie Entschlüsselung genetischer Codes ist ein bedeutender Meilenstein auf dem Weg zu individualisierter und personalisierter Medizin. Diesen Fortschritt für die Gesellschaft als Ganze nutzbar zu machen ist eine Herausforderung. Welche Strategien und Maßnahmen führen wirklich zu Gesundheit und Wohlbefinden?
| |||||
| |||||
| |||||
|
Heather DEWEY-HAGBORG
Artist; Assistant Professor of Art and Technology Studies, School of the Art Institute, Chicago
MD. Ph.D. Leroy HOOD
President and Co-Founder, Institute for Systems Biology, Seattle
| 1963-1964 | NIH Predoctoral Fellowship, California Institute of Technology |
| 1964-1967 | NIH Postdoctoral Fellowship, California Institute of Technology |
| 1967-1970 | Senior Investigator, Immunology Branch, GL&C, NCI, NIH, Bethesda, MD |
| 1970-1973 | Assistant Professor of Biology, California Institute of Technology |
| 1973-1975 | Associate Professor of Biology, California Institute of Technology |
| 1975-1977 | Professor of Biology, California Institute of Technology |
| 1977-1992 | Bowles Professor of Biology, California Institute of Technology |
| 1980-1989 | Chairman, Division of Biology, California Institute of Technology |
| 1981-1992 | Director, Cancer Center, California Institute of Technology |
| 1992-1999 | William Gates III Professor & Chairman, Department of Molecular Biotechnology, School of Medicine, University of Washington |
| 1989-2000 | Director, NSF Science & Technology Center for Molecular Biotechnology, Caltech |
| since 1992 | Affiliate Professor, Departments of Bioengineering, Computer Science & Immunology |
| President and Professor, Institute for Systems Biology, Seattle, WA |
Ph. D. Calum MACKELLAR
Director of Research, The Scottish Council on Human Bioethics Ltd., Edinburgh
| 1991-1992 | Postdoctoral Research Fellowship studying the synthesis and applications of genetic antivirals as potent drugs against AIDS/HIV, University of Edinburgh and the Medical Research Council |
| 1993-1997 | Associate, Synthesis of New Kinds of Drugs for Gene-Therapy, Link Technologies Ltd, Glasgow Research and Development |
| 1997-2001 | Visiting/Associate Lecturer in Biological Chemistry and Bioethics, Queen Margaret University, Edinburgh |
| 2001-2003 | Senior Civil Servant, Bioethics Division in the Directorate General of Legal Affairs, Council of Europe Strasbourg |
| since 2003 | Director of Research, Scottish Council on Human Bioethics, Scottish Charity, Edinburgh |
| since 2010 | Visiting Lecturer & Visiting Professor of Bioethic, St Mary s University, Twickenham, London |
Emilio GALLI-ZUGARO
Chairman, Methodos S.p.A., Milan; Founder, Orvieto Academy for Communicative Leadership, Munich/Orvieto
| Studied Political Sciences in Würzburg and Rome | |
| 1980-1985 | Communcation functions in public service, Rome |
| 1985-1992 | Journalist for FORTUNE, Wirtschaftswoche, L'Independente, Italia Oggi, Il Giornale, Finanz und Wirtschaft, The European |
| since 1996 | Author and Scholar, Ludwig-Maximilians-University, Munich |
| since 2000 | European School of Management and Technology, Berlin |
| 1992-2015 | Head of Group Communications, Allianz SE, Munich |
| since 2015 | Chairman of Methodos, S.p.A., Milan |
| Executive coach and mentor, Entrepreneurship Center, Munich | |
| since 2017 | Founder, Orvieto Academy for Communicative Leadership, Orvieto |
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
